Less Ads, More Data, More Tools Register for FREE

Pin to quick picksZotefoams Plc Regulatory News (ZTF)

Share Price Information for Zotefoams Plc (ZTF)

Share Price is delayed by 15 minutes
Get Live Data
459.00    6.00 (1.32%)
Bid:
462.00
Ask:
467.00
Spread: 5.00 (1.082%)
Market Cap: £225.74m
ZTF Live PriceLast checked at - London Stock Exchange

Intraday Zotefoams Plc Share Chart

Interim Management Statement

26 Oct 2012 07:00

RNS Number : 5898P
Zotefoams PLC
26 October 2012
 



26 October 2012

 

Zotefoams plc

("Zotefoams" or "the Company")

 

Interim Management Statement for the Quarter ended 30 September 2012

 

26 October 2012 - Zotefoams, which manufactures and sells high-performance foams, today announces its interim management statement for the third quarter ended 30 September 2012.

 

Third quarter Polyolefin foam sales increased by approximately 3% in constant currency compared to the same period last year. Sales growth in North America and Rest of World was around 6% while we experienced more modest growth in UK and Continental Europe. The impact of a weaker euro reduced the sterling value of European sales by approximately 10% while there was a small positive impact on sales elsewhere from relative US dollar strength compared with the third quarter in 2011.

 

In the third quarter of 2011 there was high demand for our T-Tubes® insulation products and, due to timing of projects, comparative sales were much lower in 2012. As a result, revenue from our High-Performance Polymers ("HPP") segment was approximately 20% below the same period last year despite an increase in sales of our patented ZOTEK® F fluoropolymer foams. While sales in HPP have historically been subject to short term fluctuations, we remain confident of strong underlying growth in this segment, much of which is to the aviation market.

 

In July and August 2012 MuCell Extrusion LLC ("MEL"), which licenses foaming technology, made important advances within the film and sheet markets. Agreements with Dow Chemical and Styron to license-in their complementary patents have enhanced our ability to offer attractive licences in packaging technology, and activity and interest levels have increased as a direct result. The development pipeline of new projects continues to grow from a small base and in the medium term we expect good progress in conversion of additional signed MEL licences. Currently MEL is a developmental business which is cash generative and we are increasing investment commensurate with our expectations for growth over the coming years.

 

For the third quarter the euro-denominated price of low density polyethylene (LDPE), our main raw material, was at a similar average price compared to the same period last year.

 

The Company continues to progress, with a forward order book into early 2013. Although we are mindful of the uncertain economic environment and the potential for movements in exchange rates to have a translation impact on our reported results, the Board remains confident of a satisfactory outcome for the year and continued progress in the future.

 

 

Enquiries:

Zotefoams plc

0208-664-1600

David Stirling, Managing Director

Clifford Hurst, Finance Director

FTI Consulting

0207-831-3113

Ben Brewerton, John Dineen, Victoria Foster Mitchell

 

About Zotefoams plc

Zotefoams plc (LSE - ZTF) is a world leader in cellular material technology. Using a unique manufacturing process with environmentally friendly nitrogen expansion, Zotefoams produces lightweight foams in Croydon, UK and Kentucky, USA for diverse markets worldwide through its global sales force. Zotefoams also owns and licenses patented MuCell® microcellular foam technology from a base in Massachusetts, USA to customers worldwide and sells T-Tubes® advanced insulation systems made from its patented ZOTEK® fluoropolymer foams.

 

www.zotefoams.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSUVSBRUSARUAA
Date   Source Headline
12th May 20117:00 amRNSAGM Statement
3rd May 201112:54 pmRNSTotal Voting Rights
13th Apr 20115:01 pmRNSNotice of AGM
4th Apr 201111:04 amRNSDirector/PDMR Shareholding
31st Mar 20113:04 pmRNSDirector/PDMR Shareholding
31st Mar 20117:00 amRNSAcquisition of MuCell and Share Placing
23rd Mar 20113:24 pmRNSDirector/PDMR Shareholding
8th Mar 20117:00 amRNSFinal Results
14th Feb 20113:47 pmRNSHolding(s) in Company
4th Jan 20113:00 pmRNSHolding(s) in Company
22nd Dec 20103:49 pmRNSHolding(s) in Company
21st Dec 20107:00 amRNSTrading Statement
16th Dec 201012:11 pmRNSHolding(s) in Company
2nd Dec 20109:32 amRNSDirectorate Change
17th Nov 20103:55 pmRNSHolding(s) in Company
17th Nov 20103:52 pmRNSHolding(s) in Company
12th Nov 20103:05 pmRNSDirector/PDMR Shareholding
22nd Oct 20107:00 amRNSInterim Management Statement
22nd Oct 20107:00 amRNSInterim Management Statement
12th Oct 20108:14 amRNSHolding(s) in Company
28th Sep 20105:41 pmRNSHolding(s) in Company
28th Sep 20105:39 pmRNSHolding(s) in Company
28th Sep 20101:00 pmRNSHolding(s) in Company
27th Sep 20103:02 pmRNSHolding(s) in Company
11th Aug 201010:57 amRNSHolding(s) in Company
9th Aug 20103:27 pmRNSHolding(s) in Company
3rd Aug 20107:00 amRNSHalf Yearly Report
1st Jul 20107:00 amRNSTrading Statement
9th Jun 201012:24 pmRNSHolding in company - amendment
9th Jun 201010:32 amRNSHolding(s) in Company
28th May 20103:31 pmRNSAnnual Information Update
17th May 20107:00 amRNSDirector/PDMR Shareholding
13th May 20103:00 pmRNSResult of AGM
11th May 20107:00 amRNSAGM Statement
7th May 20104:06 pmRNSDirector/PDMR Shareholding
12th Apr 20107:00 amRNSNotice of AGM
7th Apr 20104:30 pmRNSDirector/PDMR Shareholding
29th Mar 20108:50 amRNSHolding(s) in Company
24th Mar 201012:46 pmRNSHolding(s) in Company
23rd Mar 20102:40 pmRNSDirector/PDMR Shareholding
15th Mar 20104:52 pmRNSDirector/PDMR Shareholding
9th Mar 20107:00 amRNSFinal Results
3rd Mar 20102:36 pmRNSHolding(s) in Company
10th Dec 20092:30 pmRNSTrading Statement
23rd Oct 20097:00 amRNSInterim Management Statement
9th Oct 20093:08 pmRNSHolding(s) in Company
8th Sep 20092:13 pmRNSHolding(s) in Company
18th Aug 20091:36 pmRNSDirector/PDMR Shareholding
11th Aug 20095:45 pmRNSHolding(s) in Company
11th Aug 20095:15 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.